The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Buys. Follow the money. Dyor.
All trades are buys. Looks like someone in the know.
What's going on here? News re ce mark...surely any info would be public!!
Ooos you spoke too early
Zzzzzzzzz No news, little trading and a stagnant share price. Why bother listing onto AIM in the first place?
To sucker idiots like me into buying shares you say?
Director's at COS have a hefty amount of shares, and agree that they will also want to see a return on them. This is a waiting game now until proprietry products get CE mark/registration and they can start selling them.
Great potential but testing times at the moment.
imo of course......
Director's at COS have a hefty amount of shares, and agree that they will also want to see a return on them. This is a waiting game now until proprietry products get CE mark/registration and they can start selling them.
Great potential but testing times at the moment.
imo of course......
I am disappointed at the present share price but take some comfort from the fact that on 27 July 17 a director purchased 900,000 shares at 5.1p.
One assumes he wants to see a return on his investment?
You can access on the company website.
As a company they need to share more of this information. Also some news on how long the CE registration will take would be interesting.Then they can start actually selling this Proprietary product. Not all doom n gloom....imo...but not far off it...
No point in selling this now, hold for better news.
A bit in the rns says they signed a major contract last month ? Cant find an rns stating this.
Part of me is tempted to average down but with a 12% spread....
The results not all bad and they are sat on cash, if anything I see them as potential bid target from a larger player.
Willing to wait and see for another year as small cap punts volatile and the drop today overdone imo.
Oh well...at least plenty of cash still there. Honest summation from the ceo.
Hopefully a practice run for tomorrow :)
It is... contract news with results would be nice. Would like to think things are improving...we shall see. atb
http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27701566&ArticleHeadline=China_Grand_affiliate_makes_offer_to_acquire_Sinclair_Pharma
Chinese buying small pharma outfits.
In 2 days.
Few buys coming in now...hopefully all positive next tuesday.
This is a good video showing an overview of what Collagen Soulutions do.
Worth a look if thinking about COS.
http://www.piworld.co.uk/2018/03/01/collagen-solutions-cos-investor-presentation-26th-february-2018/
One week today.
Results soon..expecting some good news.
Still holding for better news and sp gain but reviewed the FT tearsheet for COS which said:
"Collagen Solutions PLC appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 8.98m. In fact, 0.95% of the value of Collagen Solutions PLC shares can be attributed to this cash."
A little disappointed that we are not closer to 5p!
Oops excuse my typo.Promosing as it is!!! Basically article saying COS is one of the bigger players in the US. Looks promIsing...... imo "The report also provides profiles of leading players operating in the global bovine-based collagen for biomedical applications market. Collagen Solutions LLP and Medtronic are the major players operating in the market, offering products with proprietary technologies." Collagen Solutions LLP operates under COS.
http://www.prnewswire.co.uk/news-releases/bovine-based-collagen-for-biomedical-applications-market-to-be-worth-us-12000-mn-by-2025-says-tmr-683552141.html Growth in this sector looking promosing. News today about it. Could do with some good news on this. All looking good imo.
There wont be any concrete orders until the CE Mark is awarded and partnerships take time to develop. This is a long term opportunity so buy to average down but not in the hope of a big rise in the SP from Esska. I've exhibited at many shows and its an educational process.